The human papillomavirus (HPV) vaccine can protect one in two girls from one of the biggest causes of cervical cancer, according to a study of the first results on HPV effectiveness in Africa.

A new partnership between Gavi and Girl Effect is using the power of mass media to bust myths and help reverse the decline in vaccine coverage across Africa

More than 3,200 Kenyan women die of vaccine-preventable cervical cancer each year, but teenage athlete Stecy Bosse of Kisumu is racing to change that.

Cervical cancer is one of the most common cancers in women. Mortality rates in sub-Saharan Africa are three times higher than the global average.

HPV-linked cancers – which are vaccine preventable in most cases – are a particular threat to trans people, a review study recently found. 

The small Himalayan country of Bhutan plans to eliminate cervical cancer, and sees vaccinating boys as well as girls as being crucial to that goal.

The second commonest cancer among women aged 15 to 44, and often diagnosed late, cervical cancer has a brutal mortality rate in Eritrea. Now, community health workers are pushing prevention.

Professor Nayi Zongo is the President of the Burkinabe Coalition Against Cancer (COBUCAN). We discuss the importance of vaccination against human papillomavirus to prevent cervical cancer, which claims the lives of hundreds of women each year in…

Zambian broadcaster Karen Nakawala was diagnosed with cervical cancer four years ago. She survived, though many friends she made didn’t. Today she’s on a mission to convince girls across the world to get the HPV vaccine.

Southern and East African countries have some of the highest rates¹ of cervical cancer in the world. Prof Lynette Denny explains why, and what is being done to improve women’s health.

Cervical cancer is vaccine-preventable in 95% of cases. It also remains Uganda’s single most common cancer, affecting three times as many women and girls there than on global average. VaccinesWork finds out why.

Dr Samiratou Ouédraogo is a lecturer at Joseph Ki-Zerbo University in Burkina Faso, deputy coordinator of the ReAAC (Research and Action Against Cancer) Chair, and also co-founder of Women in Global Health in French-speaking West Africa. She…

In rural areas of South Africa, women with cervical cancer are often diagnosed late, and hospitals don’t necessarily have the resources to care for them, says Dr Nwabisa Giyose.

Professor Bangaly Traoré is the coordinator of the national cancer control programme in the Republic of Guinea. In this interview, we discuss the importance of vaccination against human papillomavirus, which can cause cervical cancer.

Although cervical cancer is almost entirely preventable by a vaccine against the causative human papillomavirus, many still don’t have access to it, nor do they have access to screening for early detection. This needs to change if the cancer is…

WHO said this year that just one dose of the vaccine against cervical cancer is protective. Now a study has confirmed that the immune response remains strong ten years post-vaccination.

In a blow against cervical cancer, 94% of Uzbek girls aged 12 to 14 have gotten a first dose of the vaccine against the human papillomavirus.

A new human papillomavirus (HPV) vaccine has been launched by the Serum Institute of India, offering a low-cost alternative to vaccines on the market.

More than 15 years have passed since the first HPV vaccine introduction, and real-world evidence for its effectiveness is now well established. However the global burden of HPV-related cervical cancer has shifted to lower-income countries, where…

Girls and women hold the key to improving access to healthcare for families across Ethiopia and Tanzania, starting with the HPV vaccine.

More than 150,000 girls across Sierra Leone will have access to the HPV vaccine after the government introduced it into the routine immunisation programme.

Kunle Afolayan gives a fresh insight into what it’s like to be a cancer patient in modern Nigeria, teaching vital lessons on the way.

New data hints at potential expanded role for the HPV vaccine, pending further research

Seven years after it ended, Lesotho has relaunched its HPV vaccination programme.

The Kingdom of Eswatini is preparing for the nationwide rollout of one of the world’s biggest lifesavers: the Human Papillomavirus (HPV) vaccine.

There are lessons to be learned from Punjab’s approach to increasing HPV vaccination rates.

Cervical cancer kills one woman every two minutes, but the need for two or three doses is a major reason why vaccine uptake has been slow – this finding should mean many more lives are saved through HPV vaccination.

Strategies to ensure effective HPV vaccinations in Kenya have been modified to boost rollout of the COVID-19 vaccine.

With cervical cancer killing one woman every two minutes, rolling out the HPV vaccine that can almost entirely prevent this killer disease is essential.

In 2021, led by the Lao Women’s Union, Laos made a commitment to combat HPV.

Kenya has been systematically rolling out the HPV vaccine – which prevents the leading cause of cervical cancer – in schools.

Real world data from the UK shows the value of vaccinating girls against human papilloma virus (HPV) when they are 12 to 13 years of age.

COVID-19 has caused a decline in the delivery of human papillomavirus (HPV) vaccines that protect girls from cervical cancer. Anuradha Gupta, the Deputy CEO of Gavi, explains what we must do to create more access to these vaccines.

In Tanzania, the Ocean Road Cancer Institute is doing its part to ensure that people across the country can receive cancer treatment and care, regardless of their ability to pay.

Global access to HPV vaccine is vital, particularly in lower-income countries. Lessons learned from HPV roll-out could boost uptake of COVID-19 vaccines.

As World Cancer Day approaches amidst the COVID-19 pandemic,  it’s now more important than ever to ensure continued access to HPV vaccines to eliminate cervical cancer around the world.

The world’s most comprehensive study reveals all! A new study looking at the impact of vaccinations in 98 countries over the past 20 years concludes that 37 million people are alive today thanks to vaccines.

New review of evidence on a single-dose HPV vaccination schedule is published by PATH-led consortium.

New girl-centered toolkit helps health officials develop and implement communications campaigns that resonate with girls in their countries.

Nearly half a million girls to be protected each year following the launch of the HPV, which will be provided with financial support from Gavi, the Vaccine Alliance. Here’s a closer look at the launch ceremony.

PATH offers new vaccine cost calculators to equip countries making the most of their resources.

Anti-vaxxers’ irresponsible misinformation ignores those with the most to lose by not vaccinating: the poorest and most vulnerable, who risk dying or sliding into medical impoverishment if they or their loved ones get sick. For much of the world’…

New research found a direct link between the human papillomavirus vaccine and a lowered risk of developing cervical cancer, with vaccinating children before the age of 17 having the greatest impact.

Snapshots from DRC, India and Zambia illustrate country ownership and progress in the fights against Ebola, polio and HPV.

When I was 12, I received the HPV vaccine just like most girls my age in Rwanda. The day after we got the first dose, my classmates started spreading rumours about the vaccine that they had heard from their families and communities.

In Malawi, primary school drop-out rates are among the highest in Africa. To try and guarantee high coverage, the HPV vaccine is administered to 9-years-old girls.

Helping rural and urban girls across Ethiopia understand cervical cancer and HPV.

Lower-income countries are seeing better vaccination coverage than they have had in decades, but the COVID-19 pandemic is threatening to hamper progress.

The country has made strategic investments including supply chain strengthening and technological innovation, all of which have allowed critical immunisation activities to continue during and beyond the quarantine.

UICC’s Director of Special Projects, Dr Julie Torode, highlights the importance of continuing to push forward with the global strategy to eliminate cervical cancer despite the current coronavirus pandemic.